Nil Ratan Sircar Medical College & Hospital (NRSMC&H)

SL

List of ongoing research projects in each department (by students & faculties) individually and in collaborationswithin the academic community / Industry. The name, desigrration and field of expertise of Principal Investigator,Co-PI and any other related to the project must be clearly mentioned and authenticated by Head of the Institution

Funding sources and grants allocated for health and clinical research endeavours for each research project must be

mentioned clearly

Overview of current research infrastructure and facilities available in medical colleges (Department wise and

multidisciplinary/ multicentric)

Publication output and dissemination of research findings in the last two years.

Status of Institutional Ethics Committee (DCGI approved) with its SOP.

1.

A Double-Blind, placebo- controlled study of nebulized revefenacin inhalation solution in Indian Subjects with Moderate to Very Severe chronic            obstructive pulmonary disease (COPD).

Protocol No.: REVE-SGR- 3001

PROF. (DR.) JAYDIP DEB

DR. PRIYANKA RAY

Funded by Infoclin Consultancy (Paid by cheque to Principal, NRSMC, Kolkata)

(Copy attached)

Available multicentric

On process

Approved

2.

A Phase 4, open-label, single arm, 24-week, phase 4 study to evaluate the safety and efficacy of Mepolizumab 100 mg SC administered every 4 weeks in Indian participants aged

≥18 years with Severe eosinophilic asthma requiring oral corticosteroid treatment to Maintain asthma control (PRISM)

Study ID: 209682/ PRISM

Study

PROF. (DR.) JAYDIP DEB

DR. PRIYANKA RAY

Funded by Infoclin Consultancy (Paid by cheque to Principal, NRSMC, Kolkata)

(Copy attached)

Ongoing multicentric

On process

Approved

3.

A randomized, double – blind, four – arm active and placebo – controlled dose – finding trial to evaluate the efficacy, tolerability, safety and dose response of LYT – 100 in patients with idiopathic pulmonary fibrosis (IPF)

PROF. (DR.) JAYDIP DEB

DR. PRIYANKA RAY

Funded by Infoclin Consultancy

Yet to start

--------

Approved

4.

A multicentre, randomized, double-blind, placebo-controlled, phase – III study to evaluate the efficacy, safety and tolerability of BMS – 986278 in participants with idiopathic pulmonary fibrosis(IPF)

PROF. (DR.) JAYDIP DEB

DR. SASWATA GHOSH

Funded by Infoclin Consultancy

Yet to start

--------

Approved

A multicentre, randomized, double-blind, placebo-controlled, phase – III study to evaluate the efficacy, safety and tolerability of BMS – 986278 in participants with progressive pulmonary fibrosis (PPF)

PROF. (DR.) JAYDIP DEB

DR. SASWATA GHOSH

Funded by Infoclin Consultancy

Yet to start

--------

Approved

5.

Protocol Number: 212655

Protocol Title: Phase IV, 12-week, single arm, open label study evaluating the safety and efficacy of fixed dose triple combination FF/UMEC/VI administered once daily in the morning via a dry powder inhaler in participants with chronic obstructive pulmonary disease in India.

PI:- DR. JAYDIP DEB

CO-PI:- DR SASWATA GHOSH

Funded by IQVIA RDS INDIA PVT LTD

Available

Pending

Approved